0001415889-22-004365.txt : 20220429
0001415889-22-004365.hdr.sgml : 20220429
20220429163051
ACCESSION NUMBER: 0001415889-22-004365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220428
FILED AS OF DATE: 20220429
DATE AS OF CHANGE: 20220429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DWEK RAYMOND
CENTRAL INDEX KEY: 0001231617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 22876151
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-04292022_040401.xml
X0306
4
2022-04-28
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231617
DWEK RAYMOND
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
true
false
false
false
Common Stock
2022-04-28
4
M
0
2000
48.11
A
2000
D
Common Stock
2022-04-28
4
D
0
2000
179.34
D
0
D
Share Tracking Award
48.11
2022-04-28
4
M
0
2000
0
D
2013-06-26
2022-06-26
Common Stock
2000
2000
D
This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
/s/ John S. Hess, Jr. under Power of Attorney
2022-04-29